PT1406927E - Glicopéptidos, sua preparação e utilização no diagnóstico ou no tratamento terapêutico da esclerose múltipla - Google Patents

Glicopéptidos, sua preparação e utilização no diagnóstico ou no tratamento terapêutico da esclerose múltipla Download PDF

Info

Publication number
PT1406927E
PT1406927E PT02745396T PT02745396T PT1406927E PT 1406927 E PT1406927 E PT 1406927E PT 02745396 T PT02745396 T PT 02745396T PT 02745396 T PT02745396 T PT 02745396T PT 1406927 E PT1406927 E PT 1406927E
Authority
PT
Portugal
Prior art keywords
glycopeptides
multiple sclerosis
diagnosis
preparation
therapeutic treatment
Prior art date
Application number
PT02745396T
Other languages
English (en)
Inventor
Anna Maria Papini
Mario Chelli
Paolo Rovero
Francesco Lolli
Original Assignee
Univ Firenze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1406927(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Firenze filed Critical Univ Firenze
Publication of PT1406927E publication Critical patent/PT1406927E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
PT02745396T 2001-06-22 2002-06-19 Glicopéptidos, sua preparação e utilização no diagnóstico ou no tratamento terapêutico da esclerose múltipla PT1406927E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001FI000114A ITFI20010114A1 (it) 2001-06-22 2001-06-22 Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla

Publications (1)

Publication Number Publication Date
PT1406927E true PT1406927E (pt) 2008-07-31

Family

ID=11442221

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02745396T PT1406927E (pt) 2001-06-22 2002-06-19 Glicopéptidos, sua preparação e utilização no diagnóstico ou no tratamento terapêutico da esclerose múltipla

Country Status (15)

Country Link
US (1) US7037893B2 (pt)
EP (1) EP1406927B1 (pt)
AT (1) ATE393785T1 (pt)
AU (1) AU2002316989B2 (pt)
CA (1) CA2451347C (pt)
CZ (1) CZ2004122A3 (pt)
DE (1) DE60226324T2 (pt)
DK (1) DK1406927T3 (pt)
ES (1) ES2305258T3 (pt)
HU (1) HUP0400262A3 (pt)
IL (2) IL159479A0 (pt)
IT (1) ITFI20010114A1 (pt)
PL (1) PL207174B1 (pt)
PT (1) PT1406927E (pt)
WO (1) WO2003000733A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
ITFI20010144A1 (it) * 2001-07-25 2003-01-25 Univ Firenze Colonne per immunoassorbimento per sottrazione di autoanticorpi dal sangue con tecniche di plasmafiltrazione selettiva
WO2004015420A1 (en) * 2002-08-02 2004-02-19 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US20080267988A1 (en) * 2007-04-11 2008-10-30 Enteron Limited Partnership Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
CA2683865A1 (en) 2007-04-12 2008-10-23 Apitope International Nv Biomarkers for multiple sclerosis
ATE514711T1 (de) 2007-10-16 2011-07-15 Toscana Biomarkers S R L Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen
US20100203569A1 (en) 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
ITFI20120164A1 (it) 2012-06-05 2013-12-06 Azienda Ospedaliera Universitaria S Enese 50 Nuovi peptidi glicosilati.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035879A1 (en) 1996-03-28 1997-10-02 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
EP1080185A4 (en) 1998-05-05 2005-01-26 Corixa Corp BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF.
US6333033B1 (en) 1998-08-26 2001-12-25 The Regents Of The University Of California Autoantibody inhibitors
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
ITRM20010408A1 (it) * 2001-07-10 2003-01-10 Univ Napoli Federico Ii Mini-anticorpo umano citotossico per cellule tumorali che esprimono il recettore erbb2.

Also Published As

Publication number Publication date
EP1406927B1 (en) 2008-04-30
AU2002316989B2 (en) 2006-10-26
HUP0400262A2 (hu) 2004-08-30
IL159479A (en) 2010-12-30
PL368158A1 (en) 2005-03-21
US7037893B2 (en) 2006-05-02
WO2003000733A2 (en) 2003-01-03
US20040235713A1 (en) 2004-11-25
WO2003000733A3 (en) 2003-11-13
CA2451347C (en) 2011-07-19
EP1406927A2 (en) 2004-04-14
PL207174B1 (pl) 2010-11-30
IL159479A0 (en) 2004-06-01
ITFI20010114A1 (it) 2002-12-22
CZ2004122A3 (cs) 2004-07-14
HUP0400262A3 (en) 2008-05-28
CA2451347A1 (en) 2003-01-03
DE60226324T2 (de) 2009-07-09
ATE393785T1 (de) 2008-05-15
DE60226324D1 (de) 2008-06-12
DK1406927T3 (da) 2008-08-18
ES2305258T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
WO2003039462A3 (en) B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
WO2005027733A3 (en) Biological markers for diagnosing multiple sclerosis
WO2003008583A3 (en) Novel compositions and methods for cancer
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
WO2003061593A3 (en) Novel targeted compositions for diagnostic and therapeutic use
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2003066661A3 (en) Human dr4 antibodies and uses thereof
MXPA03008739A (es) Anticuerpos recombinantes asociados a gangliosidos. su uso en el diagnostico y tratamiento de tumores.
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
WO2003045230A3 (en) Novel compositions and methods for cancer
EP2034030A3 (en) Novel compositions and methods for cancer
WO2003084384A3 (en) Diagnosis of flavivirus infection
AU2002219137A1 (en) Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
WO2004047757A3 (en) Diagnosing and treating hematopoietic cancers
WO2002066075A3 (en) Biotin-derivatives and their conjugates with chelating agents
WO2003035837A3 (en) Novel compositions and methods for cancer
EP2322559A3 (en) Neoplasm specific antibodies and uses thereof
WO2002024738A1 (en) β-CATENIN NUCLEAR LOCALIZED PROTEIN
WO2003039484A3 (en) Novel compositions and methods for cancer
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
AU2002365104A8 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof